Clinical trial
SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV)…
NCT00002310 · Shaman Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00002310 |
|---|---|
| Title | SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir |
| Official title | A Pilot Study to Determine the Safety and Efficacy of Topically Applied SP-303T in Patients With Acquired Immunodeficiency Syndrome and Concomitant Herpes Simplex Virus (HSV) Infection Unresponsive to Acyclovir |
| Lead sponsor | Shaman Pharmaceuticals, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Herpes Simplex, HIV Infections |
| Intervention type | Drug |
| Interventions | Crofelemer |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: